documents: FDA-2025-N-4622-0023

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-N-4622-0023 FDA FDA-2025-N-4622 Reference 21 - FDA, “CDRH Announces Intent to Initiate the Reclassification Process for Most High Risk IVDs,” January 31, 2024 Supporting & Related Material Background Material 2025-11-25T05:00:00Z 2025 11     2025-11-25T19:52:27Z   0 0 09000064b909ad51

Links from other tables